When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KYKOF - Kyowa Hakko Kirin tries a second time with Parkinson's med istradefylline
Kyowa Hakko Kogyo
The FDA accepts for review Kyowa Hakko Kirin Co., Ltd.'s (OTCPK:KYKOF) resubmitted marketing application seeking approval for istradefylline, a selective adenosine A2A receptor antagonist, as an adjunct to levodopa/carbidopa in adult Parkinson's disease patients experiencing "OFF" episodes.
More news on: Kyowa Hakko Kirin Co., Ltd., Healthcare stocks news,